Tamiflu Data Reassures FDA Panel; Label Changes To Stress Flu’s Role In AEs
Executive Summary
Despite the fact that safety questions linked to Roche's influenza drug Tamiflu (oseltamivir) are still lingering, the data on the drug presented by the firm to FDA's Pediatric Advisory Committee is proof that the "system worked," panelists said at the Nov. 27 meeting